# PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy

> **NCT01519856** · — · COMPLETED · sponsor: **Desitin Arzneimittel GmbH** · enrollment: 908 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** piribedil (Clarium)

## Key facts

- **NCT ID:** NCT01519856
- **Lead sponsor:** Desitin Arzneimittel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 908 (ACTUAL)
- **Last updated:** 2016-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01519856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01519856, "PIRLONG-PD Safety and Efficacy of Piribedil in Parkinson's Disease During Long Term Therapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01519856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*